Nour Ziyadeh

Nour Ziyadeh, MS, CCRP has a diverse range of experience in various roles within the pharmaceutical and clinical research industry. Most recently, Nour worked as the Director - GCP Quality at X4 Pharmaceuticals starting in 2023. Prior to that, Nour held positions at Talaris Therapeutics, Alnylam Pharmaceuticals, Alexion Pharmaceuticals, Enobia Pharma, Ora Inc., Ora Inc. (Ophthalmic Research Associates), Biogen Idec, Health Policy Associates, and The Middle East Partnership Initiative (MEPI), where Nour gained experience in clinical operations, clinical trial management, research coordination, training and compliance, and program supervision. Nour's strong background in these areas demonstrates their expertise and commitment to advancing the field of clinical research.

Nour Ziyadeh holds a Master's Degree in Clinical Research Organization and Management from Drexel University College of Medicine, which was obtained from 2012 to 2014. Prior to that, Nour obtained a Bachelor of Science in Biology from Bates College, attending from 2000 to 2004. Nour completed their secondary education at Hamden Hall Country Day School from 1997 to 2000. In addition, Nour holds a certification as a Certified Clinical Research Professional from SoCRA, which was obtained in November 2019.